Pierre Fabre
New ways to care  

SECAUCUS, NJ (June 18, 2025): Pierre Fabre Laboratories, a global healthcare company originated from France, announces the inauguration of its new US office located on 500 Plaza Drive, in Secaucus, NJ which will host its dermo-cosmetics and medical care subsidiaries. Pierre Fabre is the world’s second-largest dermo-cosmetics manufacturer and a global player in oncology, cell & gene therapy, rare disease and dermatology. This strategic move in the US marks a pivotal moment in the company’s growth strategy, underscoring its strong commitment to advancing in the US in both dermo-cosmetics and medical care. Pierre Fabre Laboratories introduced global dermo-cosmetics brands Avène, Klorane and René Furterer to the US market in the 1990’s. With an ever-growing desire for French dermo-cosmetics, the US dermo-cosmetics business has become a top priority. Building upon their success in oncology and dermatology in Europe and Asia, the company has recently expanded its medical care investments in the US through the creation of a dedicated pharmaceutics unit, Pierre Fabre Pharmaceuticals (PFP). This subsidiary is focused on continuing to deliver breakthrough therapies in rare diseases and oncology to American patient populations with high unmet needs and limited treatment options.

PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical needs in non-small cell lung cancer ("NSCLC")

Find the 2025 annual report (2024 figures) online. We have placed this year’s annual report under the sign of a “new energy” resulting in :  International growth Therapeutic innovations Medical leadership Financial solidity Collective commitment  

Malignant melanoma is a type of skin cancer that starts and develops in cells known as melanocytes – these cells are found in the upper layer of the skin and produce a pigment called melanin, giving skin its colouri. Melanoma, although less common than other skin cancers, is more dangerous because it grows and spreads quickly to other parts of the body if undetected and not treated early.i ii,  Anyone can suffer from melanoma, but it is more commonly reported among light-skinned populations, partly attributable to decreased photoprotection from reduced melanin.ii,iii Recognising the signs and symptoms of melanoma is important for early detection, diagnosis and improved treatment outcomes.iv Skin cancer can develop anywhere on the body; in places we cannot see and would not expect.v Whilst sun-exposed skin is most at risk, unusual changes to skin can also develop in areas that are usually protected from the sun (soles of feet, between fingers and toes, back, etc).v,vi Both self-evaluation and examination by others (including friends, family, or a doctor), are important for checking all areas of your skin for signs of melanoma.vi We Have Your Back Campaign This year, Pierre Fabre is re-launching a campaign entitled ‘We Have Your Back’. 

In line with Pierre Fabre Laboratories' vision "Every time we care for a single person, we make the whole world better" the MSL (Medical Science Liaison) role is crucial in enhancing patient care. As a scientific bridge between the medical community and the Pierre Fabre Laboratories, the MSL combines pharmaceutical innovation with medical expertise to develop collaboration with healthcare professionals and optimize daily healthcare practices. The MSL's objectives can be achieved through various missions, including: Medical Education: promoting best practices for up-to-date patient management. Insight Collection: gaining a comprehensive understanding of patient treatment practices, organization, and patient journey. Data Needs Identification and participation to their generation to promote best practices for patient treatment. Support Clinical Development and Real-World Evidence Projects. Understanding patient needs. Click to discover in this infographic the multifaceted life of our MSLs, their missions, skills, and roles at Pierre Fabre Laboratories.   Dive into the MSL experience through a series of 10 monthly interviews. The series will share their professional journeys, highlighting the realities and successes they encounter, and provide a glimpse into their commitment to advancing medical care.   #1  Emeline Mathieu: A Passionate Medical Science Liaison (MSL) Advancing Healthcare in Australia.  #2  Pawel Pedrasik: A Passionate Medical Science Liaison (MSL) Advancing Healthcare in Poland #3 Zohra Butt: A Medical Science Liaison (MSL) Dedicated to Changing Patient Lives in the United Kingdom.  #4 Miaomiao Zhang: A Medical Science Liaison (MSL) Transforming the Therapeutic Landscape in China. #5 Selina Jansky: A Medical Science Liaison (MSL) Leading the Evolution of Healthcare Practices in Germany. 

    The script of video. •    Could you please introduce yourself? Hello, I am Anne-Sophie Paradis. I’m 37 years old. I’m a pharmacist from France, and I have worked as an MSL for Pierre Fabre for nearly 2 years.  •    What is your professional background before being an MSL?  I previously worked in the pharmaceutical industry, mainly in clinical trials. I started as clinical research associate and evolved later to a clinical project manager position.  •    How would you define the MSL role? The MSL is the scientific local key contact for the healthcare professionals of certain diseases, and the link with the pharmaceutical company. His role is to identify medical needs and support the building of scientific projects to help improve patient care.  •    What do you like about being an MSL? What I like the most about being an MSL is to build scientific collaboration with healthcare professionals, have various scientific and medical discussions, and projects depending on healthcare professional needs.  •    What is the most difficult thing for you about being an MSL? Administrative work, which is also an important part of the job.  •    What is the essential quality of an MSL for you? In my opinion, adaptability is the essential quality of an MSL.  •    What motivates you to get up in the morning as an MSL? I am motivated by scientific and medical discussions with Key Opinion Leaders, strategic involvement, by learning about medical news and by collaborating on medical projects to improve patient care.  •    What is your most beautiful emotion experienced as an MSL? Job fulfillment. Following a multidisciplinary meeting I organized, when health care professionals shared their practices, they told me they were satisfied about the content of the meeting. And what’s more, that they were willing to participate to the same kind of meeting next year.  •    Any words or advice for someone wanting to become an MSL? I would advise to have good relationship, rigor and adaptability skills, to be open-minded and to work on the field in order to have a good understanding of hospital structure.     Know more about MSL